Evidence map›Paper›PMID 32189455›Full record

ArticleCancer communications (London, England)2020

Role of eIF4E on epithelial-mesenchymal transition, invasion, and chemoresistance of prostate cancer cells.

Xujie Liu, Amita M Vaidya, Da Sun, Yan Zhang, Nadia Ayat, Andrew Schilb, Zheng-Rong Lu

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The role of m5C, m1A and m7G modifications in tumors of urinary system.Frontiers in cell and developmental biology · 2025
    Review
  2. Article
  3. Article
  4. Analysis of mFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xujie LiuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106, USA.
Amita M VaidyaDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106, USA.
Da SunDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106, USA.
Yan ZhangDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106, USA.
Nadia AyatDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106, USA.
Andrew SchilbDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106, USA.
Zheng-Rong LuDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, 44106, USA.ORCID 0000-0001-8185-9519

Funding

Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapyR01CA235152 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI ZHENG-RONG LU, William Schiemann · 2019 to 2026
$3.2M
Image-guided EMT inhibition for treating metastatic breast cancerR01CA194518 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LU, ZHENG-RONG, SCHIEMANN, WILLIAM · 2015 to 2019
$2.4M
NCI NIH HHS R01 CA194518NCI NIH HHS R01 CA235152NIH HHS R01 CA194518
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epithelial-Mesenchymal TransitionCell Line, TumorDrug Resistance, NeoplasmEukaryotic Initiation Factor-4EHumansMaleNanoparticlesNeoplasm InvasivenessProstatic NeoplasmsRNA, Small InterferingEIF4E protein, humanEukaryotic Initiation Factor-4ERNA, Small Interferingchemoresistanceepithelial-mesenchymal transitioneukaryotic translation initiation factor 4Einvasionprostate cancer

Identifiers

PMID32189455
PMCPMC7144414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.